☰

Mandeep Kaur, Ph.D. - Publications

Affiliations: 
Pharmacology and Toxicology Dartmouth College, Hanover, NH, United States 
Area:
cancer, transcription factors
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gautam N, Kaur M, Kaur S. Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review. Journal of Cancer Research and Therapeutics. PMID 33063698 DOI: 10.4103/jcrt.JCRT_1090_19  0.31
2019 Kaur M, Drake AC, Hu G, Rudnick S, Chen Q, Phennicie R, Attar R, Nemeth J, Gaudet F, Chen J. Induction and Therapeutic Targeting of Human NPM1c Myeloid Leukemia in the Presence of Autologous Immune System in Mice. Journal of Immunology (Baltimore, Md. : 1950). PMID 30710044 DOI: 10.4049/Jimmunol.1800366  0.33
2018 Chen H, Cho KS, Vu THK, Shen CH, Kaur M, Chen G, Mathew R, McHam ML, Fazelat A, Lashkari K, Au NPB, Tse JKY, Li Y, Yu H, Yang L, et al. Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma. Nature Communications. 9: 3209. PMID 30097565 DOI: 10.1038/S41467-018-05681-9  0.303
2016 Esau L, Sagar S, Bangarusamy D, Kaur M. Identification of CETP as a molecular target for estrogen positive breast cancer cell death by cholesterol depleting agents. Genes & Cancer. 7: 309-322. PMID 28050232 DOI: 10.18632/genesandcancer.122  0.301
2016 Kaur M, Hanson A, Drake A, Phennicie R, Chen J. Abstract B132: A model of de novo acute myeloid leukemia with an autologous human immune system as a preclinical tool for testing immunotherapies Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-B132  0.317
2014 Sagar S, Esau L, Moosa B, Khashab NM, Bajic VB, Kaur M. Cytotoxicity and apoptosis induced by a plumbagin derivative in estrogen positive MCF-7 breast cancer cells. Anti-Cancer Agents in Medicinal Chemistry. 14: 170-80. PMID 24164046 DOI: 10.2174/18715206113136660369  0.302
2013 Kaur M, Cole MD. MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase. Cancer Research. 73: 695-705. PMID 23135913 DOI: 10.1158/0008-5472.Can-12-2522  0.582
2012 Doe MR, Ascano JM, Kaur M, Cole MD. Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells. Cancer Research. 72: 949-57. PMID 22186139 DOI: 10.1158/0008-5472.Can-11-2371  0.393
Show low-probability matches.